InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Kelly Thomas Patrick, Chief Financial Officer. Director active across 1 company, notably Deciphera Pharmaceuticals, Inc.. Cumulatively, 12 disclosures have been recorded. Split: 0 buy · 5 sells. Total volume traded: €130k. Activity tracked since 15 December 2021. The latest transaction was filed on 15 February 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Kelly Thomas Patrick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
34,157 sharesCommon StockSEC:0000950170-24-072221:0
17,275 shares0Common StockSEC:0000950170-24-017091:0
2,435 shares@ US$14.469822.8% of flowCommon StockSEC:0000950170-24-005389:0
8,244 sharesCommon StockSEC:0000950170-23-070384:0
8,244 sharesCommon StockSEC:0001209191-23-053936:0
1,655 shares@ US$14.401815.5% of flowCommon StockSEC:0001209191-23-038755:0
16,488 shares0Common StockSEC:0001209191-23-010519:0
2,403 shares@ US$21.241333.4% of flowCommon StockSEC:0001209191-23-003994:0
1,768 shares@ US$10.7545.3% of flowCommon StockSEC:0001209191-22-038426:0
1,368 shares@ US$9.058.4% of flowCommon StockSEC:0001209191-22-011357:0
20,500 shares0Common StockSEC:0001209191-22-004078:0
11,100 shares0Common StockSEC:0001209191-21-070250:0
12 of 12 declarations
About Kelly Thomas Patrick
Kelly Thomas Patrick is Chief Financial Officer at Deciphera Pharmaceuticals, Inc. The 12 filings on record cover the period from 2021-12-17 to 2024-06-11, and within the sampled recent filings the transactions are sales totaling EUR 130017, with the modal transaction nature listed as Attribution.
